Preparation of a bromine-76 labelled analogue of epibatidine: a potent ligand for nicotinic acetylcholine receptor studies.

[1]  D. Comar,et al.  Nicotine-11C: Synthesis and distribution kinetics in animals , 1976, European Journal of Nuclear Medicine.

[2]  D. Gündisch Nicotinic acetylcholine receptors and imaging. , 2000, Current pharmaceutical design.

[3]  N. Volkow,et al.  Dopamine Receptor‐Mediated Regulation of Striatal Cholinergic Activity , 2000, Journal of neurochemistry.

[4]  N. Volkow,et al.  Occupancy of brain nicotinic acetylcholine receptors by nicotine doses equivalent to those obtained when smoking a cigarette , 2000, Synapse.

[5]  C. Crouzel,et al.  Synthesis of a fluorine-18 labeled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging. , 1999, Bioorganic & medicinal chemistry.

[6]  E. London,et al.  Synthesis and evaluation of N-[11C]methylated analogues of epibatidine as tracers for positron emission tomographic studies of nicotinic acetylcholine receptors. , 1998, Journal of medicinal chemistry.

[7]  J S Fowler,et al.  Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity. , 1997, Nuclear Medicine and Biology.

[8]  E. London,et al.  [125/123I]IPH: A radioiodinated analog of epibatidine for in vivo studies of nicotinic acetylcholine receptors , 1997, Synapse.

[9]  Y. Yonekura,et al.  Synthesis and characterization of radioiodinated (S)-5-iodonicotine: a new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computed tomography. , 1997, Chemical & pharmaceutical bulletin.

[10]  H Lundqvist,et al.  Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment. , 1997, Dementia and geriatric cognitive disorders.

[11]  E. London,et al.  Synthesis of a radioiodinated analog of epibatidine : (±)-exo-2-(2-iodo-5-pyridyl)-7-azabicyclo[2.2.1]heptane for in vitro and in vivo studies of nicotinic acetylcholine receptors , 1997 .

[12]  N. Volkow,et al.  Mapping nicotinic acetylcholine receptors with PET , 1996, Synapse.

[13]  E. London,et al.  Synthesis of a radiotracer for studying nicotinic acetylcholine receptors : (+/−)-exo-2-(2-[18F]fluoro-5-pyridyl)-7-azabicyclo[2.2.1]heptane , 1996 .

[14]  J. Krystal,et al.  Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  R Anand,et al.  Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. , 1995, Molecular pharmacology.

[16]  E. London,et al.  In vivo labeling of nicotinic acetylcholine receptors in brain with [3H]epibatidine. , 1995, European journal of pharmacology.

[17]  B. Långström,et al.  Kinetic Analysis of Regional (S)(-)11C‐Nicotine Binding in Normal and Alzheimer Brains In Vivo Assessment Using Positron Emission Tomography , 1995, Alzheimer disease and associated disorders.

[18]  E. Wong,et al.  Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine. , 1995, The Journal of pharmacology and experimental therapeutics.

[19]  M. Maziére Cholinergic neurotransmission studied in vivo using positron emission tomography or single photon emission computerized tomography. , 1995, Pharmacology & therapeutics.

[20]  M. Damaj,et al.  Pharmacological effects of epibatidine optical enantiomers , 1994, Brain Research.

[21]  A. Nordberg Human nicotinic receptors—Their role in aging and dementia , 1994, Neurochemistry International.

[22]  J. Daly,et al.  Epibatidine, a potent analgetic and nicotinic agonist. , 1994, Molecular pharmacology.

[23]  P. Merlet,et al.  Preparation and pharmacological characterization of [76Br]-meta-bromobenzylguanidine ([76Br]MBBG). , 1994, Nuclear medicine and biology.

[24]  J. Eckman,et al.  Epibatidine is a nicotinic analgesic. , 1993, European journal of pharmacology.

[25]  A. Nordberg Clinical studies in Alzheimer patients with positron emission tomography , 1993, Behavioural Brain Research.

[26]  A. Regan,et al.  A total synthesis of (±)-epibatidine , 1993 .

[27]  B. Winblad,et al.  Tacrine restores cholinergic nicotinic receptors and glucose metabolism in alzheimer patients as visualized by positron emission tomography , 1992, Neurobiology of Aging.

[28]  Y. Yonekura,et al.  Synthesis of (S)-N-[methyl-11C]nicotine and its regional distribution in the mouse brain: a potential tracer for visualization of brain nicotinic receptors by positron emission tomography. , 1992, Chemical & pharmaceutical bulletin.

[29]  E. Vogel,et al.  Small and Medium Rings, 74. Syntheses and Photoelectron Spectra of 7‐Azanorbornadiene and Related Compounds An Analysis with Fragment Orbitals , 1991 .

[30]  S. Moerlein,et al.  No-Carrier-Added Radiohalogenation Methods with Heavy Halogens , 1983 .

[31]  G. Antoni,et al.  Synthesis of some 11C-labelled alkaloids , 1982 .